ASX ANNOUNCEMENT NEW MECHANISM FINDINGS OFFER INSIGHTS INTO XARANETIDE’S PHASE 2 SIGNAL IN MORE SEVERE STROKE KEY HIGHLIGHTS • Xaranetide targets multiple pathways involved in acute brain injury. Laboratory studies strengthen the evidence for xaranetide’s ability to target several pathways...